The therapeutic and prophylactic potential of quercetin against COVID-19: An outlook on the clinical studies, inventive compositions, and patent literature

M Imran, HK Thabet, SI Alaqel, AR Alzahrani, A Abida… - Antioxidants, 2022 - mdpi.com
Quercetin is a phenolic flavonol compound with established antioxidant, anti-inflammatory,
and immuno-stimulant properties. Recent studies demonstrate the potential of quercetin …

[HTML][HTML] Selenium and COVID-19: A spotlight on the clinical trials, inventive compositions, and patent literature

MK Alshammari, W Fatima, RA Alraya… - Journal of infection and …, 2022 - Elsevier
Selenium is an indispensable trace element for all living organisms. It is an essential
structural component of several selenium-dependent enzymes, which support the human …

Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership

S Bernhard, M Kaiser, C Burri, P Mäser - Diseases, 2022 - mdpi.com
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human
African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history …

Oral brincidofovir therapy for monkeypox outbreak: a focused review on the therapeutic potential, clinical studies, patent literature, and prospects

M Imran, MK Alshammari, MK Arora, AK Dubey… - Biomedicines, 2023 - mdpi.com
The monkeypox disease (MPX) outbreak of 2022 has been reported in more than one
hundred countries and is becoming a global concern. Unfortunately, only a few treatments …

The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects

AS Alshrari, SA Hudu, F Elmigdadi, M Imran - Biomedicines, 2023 - mdpi.com
Clostridioides difficile infection (CDI) is an urgent threat and unmet medical need. The
current treatments for CDI are not enough to fight the burden of CDI and recurrent CDI (r …

Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3, 5-disubstituted isoxazole compounds based on benznidazole

DB Carvalho, PAN Costa, GB Portapilla… - European Journal of …, 2023 - Elsevier
Chagas disease and leishmaniasis are neglected diseases of high priority as a public health
problem. Pharmacotherapy is based on the administration of a few drugs, which exhibit …

Further investigations of nitroheterocyclic compounds as potential antikinetoplastid drug candidates

C García-Estrada, Y Pérez-Pertejo… - Biomolecules, 2023 - mdpi.com
Due to the lack of specific vaccines, management of the trypanosomatid-caused neglected
tropical diseases (sleeping sickness, Chagas disease and leishmaniasis) relies exclusively …

Highlights on the development, related patents, and prospects of lenacapavir: the first-in-class HIV-1 capsid inhibitor for the treatment of multi-drug-resistant HIV-1 …

T Dzinamarira, M Almehmadi, AA Alsaiari, M Allahyani… - Medicina, 2023 - mdpi.com
The multidrug-resistant (MDR) human immunodeficiency virus 1 (HIV-1) infection is an
unmet medical need. HIV-1 capsid plays an important role at different stages of the HIV-1 …

Synthetic Approaches to the New Drugs Approved During 2021

EL McInturff, SP France, CA Leverett… - Journal of Medicinal …, 2023 - ACS Publications
Each year, new drugs are introduced to the market, representing structures that have affinity
for biological targets implicated in human diseases and conditions. These new chemical …

Plant terpenoids as hit compounds against trypanosomiasis

R Durão, C Ramalhete, AM Madureira, E Mendes… - Pharmaceuticals, 2022 - mdpi.com
Human African trypanosomiasis (sleeping sickness) and American trypanosomiasis
(Chagas disease) are vector-borne neglected tropical diseases, caused by the protozoan …